Q2 2026 Holdings
Filed 2026-08-14 | 106 holdings | $766.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $50.8M | 1,500,082 | 6.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $39.7M | 1,469,971 | 5.2% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $28.2M | 108,265 | 3.7% |
| Spdr Series Trust(XBI)Put | ST STR SP BIOT | 78464A870 | $23.7M | 150,000 | 3.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $22.2M | 1,014,606 | 2.9% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $21.6M | 100,000 | 2.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $20.9M | 96,626 | 2.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $19.6M | 588,494 | 2.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $18.8M | 328,550 | 2.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $18.7M | 219,987 | 2.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $18.3M | 245,346 | 2.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $17.8M | 459,340 | 2.3% |
| Nova LTD(NVMI) | COM | M7516K103 | $13.7M | 25,169 | 1.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $12.7M | 118,800 | 1.7% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $12.5M | 417,564 | 1.6% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $11.9M | 62,530 | 1.5% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $11.5M | 269,515 | 1.5% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $10.7M | 1,620,753 | 1.4% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.6M | 8,040 | 1.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $9.4M | 17,419 | 1.2% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $9.3M | 499,029 | 1.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $9.0M | 356,534 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $9.0M | 240,868 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $8.9M | 80,400 | 1.2% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $8.5M | 100,000 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.2M | 752,983 | 1.1% |
| LAM Research Corp(LRCX) | COM NEW | 512807306 | $8.0M | 18,470 | 1.0% |
| Applied Matls Inc(AMAT) | COM | 038222105 | $8.0M | 11,040 | 1.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $7.9M | 254,250 | 1.0% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $7.8M | 50,000 | 1.0% |
| Solaredge Technologies Inc | NOTE 2.250% 7/0 | 83417MAE4 | $7.7M | 4,000,000 | 1.0% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $7.7M | 416,417 | 1.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $7.6M | 30,256 | 1.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $7.5M | 58,600 | 1.0% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $7.3M | 28,831 | 1.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.3M | 196,408 | 1.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $7.3M | 720,057 | 1.0% |
| Nuvectis Pharma Inc(NVCT) | COM | 67080T108 | $7.0M | 382,945 | 0.9% |
| Pfizer Inc(PFE) | COM | 717081103 | $6.9M | 286,000 | 0.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $6.4M | 176,663 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.3M | 105,000 | 0.8% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $6.3M | 483,747 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $5.9M | 230,834 | 0.8% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $5.8M | 120,677 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $5.7M | 112,765 | 0.7% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $5.4M | 1,019,832 | 0.7% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $5.3M | 102,000 | 0.7% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $5.3M | 249,693 | 0.7% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $5.2M | 213,671 | 0.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $5.2M | 94,265 | 0.7% |